Organization: The Hare
We invite contributions focusing on early modern theater, including but not limited to Shakespeare’s plays. The Hare is an online, peer-reviewed journal, publishing untimely reviews of books, articles, and performances in early modern theater.
This journal provides a venue for the contention and reevaluation of old scholarly work in contemporary scholarly debate. We invite you to interpret “old” creatively, though traditional reviews of recent publications will not be considered. We welcome:
• untimely reviews of books and articles that our field has overlooked or overemphasized.
• untimely performance reviews in early modern theater, emphasizing fascinating, important yet passed-over productions that have been excluded from traditional performance history.
• future-looking pieces, from theater artists and scholars for productions they would like to see produced--arguing for what they see as the Cymbeline that Philadelphia most needs today, or The Shoemaker's Holiday in Beijing, for example.
We are excited to publish untimely reviews by scholars inspired to reassess old work in order open up new possibilities for scholarship, alongside theater artists with a vision for the future of early modern performance. This journal is a venue dedicated to the value of challenging the history of our field, through which we seek to foster dramatically new perspectives, conceptual frameworks, and methodologies within the study of early modern theater.
Article submissions should be approximately 1000 – 3000 words, including all notes and references. Longer submissions will not be considered. All submissions should be sent by email, as a Microsoft Word attachment, to the editors, Casey Caldwell and Amy Kenny. The Hare does not accept concurrent submissions. Contributors should expect the peer-review process to take approximately two months.
Please contact the editors, Casey Caldwell (firstname.lastname@example.org) and Amy Kenny (Amy.Kenny@ucr.edu) with any questions. For more information: http://thehareonline.com/
Dr. Amy Kenny